Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share (BDTX)

CUSIP: 09203E105

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
58,000,000
Total 13F shares
47,903,925
Share change
-1,358,107
Total reported value
$102,516,125
Put/Call ratio
2393%
Price per share
$2.14
Number of holders
85
Value change
-$13,785,684
Number of buys
48
Number of sells
44

Quarterly Holders Quick Answers

What is CUSIP 09203E105?
CUSIP 09203E105 identifies BDTX - Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share (BDTX) as of Q4 2024

As of 31 Dec 2024, Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share (BDTX) was held by 85 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 47,903,925 shares. The largest 10 holders included T. Rowe Price Investment Management, Inc., Bellevue Group AG, Vestal Point Capital, LP, NEA Management Company, LLC, BlackRock, Inc., VANGUARD GROUP INC, TANG CAPITAL MANAGEMENT LLC, Siren, L.L.C., GEODE CAPITAL MANAGEMENT, LLC, and RENAISSANCE TECHNOLOGIES LLC. This page lists 85 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.